Health
Investigational combo therapy shows promise in treating TP53 mutant MDS and AML patients – News-Medical.Net
Myelodysplastic Syndromes (MDS) and acute myeloid leukemia (AML) are rare hematologic malignancies of the bone marrow.
Myelodysplastic Syndromes (MDS) and acute myeloid leukemia (AML) are rare hematologic malignancies of the bone marrow. They can occur spontaneously or secondary to treatment for other cancers, so called therapy related disease, which is frequently associated with a mutation of the tumor suppressor gene TP53. Standard treatment for these patients includes hypomethylating agents such as azacitidine or decitabine but unfortunately outcomes are very poor.
Patients with TP53-mutant disease, which is…
-
General14 hours agoWondering about winter | The Spectator Australia
-
Noosa News22 hours agoOz Lotto’s $70 million jackpot won by Queensland syndicate – but not all of the winners know yet
-
Noosa News21 hours agoMan charged with murder after wife found dead in suspicious house fire near Toowoomba
-
Noosa News19 hours agoCameron Hunt, 45, charged with murder after body of his wife Louise Hunt found inside their Geham home just outside Toowoomba